10x Genomics to Present at the 39th Annual J.P. Morgan Healthcare Conference
December 23 2020 - 4:03PM
10x Genomics (Nasdaq: TXG) today announced the company will be
participating in the upcoming 39th Annual J.P. Morgan Virtual
Healthcare Conference.
10x Genomics’ management is scheduled to present on
Monday, January 11 at 7:00 a.m. Pacific Time / 10:00 a.m. Eastern
Time. Interested parties may access a live and archived webcast of
the presentation on the “Investors” section of the company website
at: investors.10xgenomics.com
About 10x Genomics10x Genomics is
a life science technology company building products to interrogate,
understand and master biology to advance human health. The
company’s integrated solutions include instruments, consumables and
software for analyzing biological systems at a resolution and scale
that matches the complexity of biology. 10x Genomics products have
been adopted by researchers around the world including 97 of the
top 100 global research institutions and 19 of the top 20 global
pharmaceutical companies, and have been cited in over 2,000
research papers on discoveries ranging from oncology to immunology
and neuroscience. The company’s patent portfolio comprises more
than 950 issued patents and patent applications.
Disclosure Information10x Genomics
uses filings with the Securities and Exchange Commission, its
website (www.10xgenomics.com), press releases, public conference
calls, public webcasts and its social media accounts as means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD.
ContactsInvestorsinvestors@10xgenomics.com
Mediamedia@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jun 2024 to Jul 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jul 2023 to Jul 2024